Wikidata

(Q61918221)

English

An Efficacy and Safety Study of Golimumab (CNTO 148) in Participants With Moderately to Severely Active Ulcerative Colitis

clinical trial

In more languages

Statements

title
A Phase 3 Multicenter, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of Golimumab Maintenance Therapy, Administered Subcutaneously, in Subjects With Moderately to Severely Active Ulcerative Colitis (English)
0 references
medical condition
colitis
0 references
country
Australia
0 references
Austria
0 references
Belgium
0 references
Bulgaria
0 references
Canada
0 references
Czech Republic
0 references
Denmark
0 references
France
0 references
Germany
0 references
Hungary
0 references
India
0 references
Israel
0 references
Japan
0 references
Latvia
0 references
Lithuania
0 references
Netherlands
0 references
New Zealand
0 references
Poland
0 references
Romania
0 references
Serbia
0 references
Slovakia
0 references
South Africa
0 references
Sweden
0 references
Ukraine
0 references
start time
September 2007
0 references
end time
October 2011
0 references
number of participants
1,228
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q61918221&oldid=2149062902"